Fukushima, Japan

Shotaro Komura


 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Shotaro Komura

Introduction

Shotaro Komura is a notable inventor based in Fukushima, Japan. He has made significant contributions to the field of neutron capture therapy, particularly in the development of advanced treatment systems for cancer. With a total of 6 patents to his name, Komura's work is at the forefront of medical technology.

Latest Patents

Komura's latest patents include a neutron source for neutron capture therapy, which features a treatment system designed to evaluate boron sources for boron neutron cancer therapy (BNCT). This innovative system incorporates a substantially square secondary moderator with a central treatment chamber for a subject. Additionally, it includes four substantially identical neutron generators positioned around the secondary moderator, with the axis of each acceleration chamber passing through the center of the treatment chamber. Another significant patent is a boron neutron cancer treatment system that also utilizes a secondary moderator with a central treatment chamber. This system is equipped with eight substantially identical neutron generators, each comprising a pre-moderator block, arranged around the secondary moderator.

Career Highlights

Komura is currently employed at Adelphi Technology, Inc., where he continues to push the boundaries of medical technology. His work has been instrumental in advancing treatment options for cancer patients, showcasing his dedication to innovation in healthcare.

Collaborations

Throughout his career, Komura has collaborated with esteemed colleagues such as Melvin Arthur Piestrup and Craig Mathew Brown. These partnerships have further enriched his research and development efforts.

Conclusion

Shotaro Komura's contributions to neutron capture therapy exemplify the impact of innovative thinking in the medical field. His patents and ongoing work at Adelphi Technology, Inc. highlight his commitment to improving cancer treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…